热门资讯> 正文
Apogee Therapeutics报告第二季度业绩
2025-08-12 02:00
- Apogee Therapeutics press release (NASDAQ:APGE): Q2 Net loss was $66.1 million for the quarter ended June 30, 2025, compared to a net loss of $33.8 million for the quarter ended June 30, 2024.
- Cash, cash equivalents and marketable securities were $621.2 million as of June 30, 2025, compared to $681.4 million as of March 31, 2025.
More on Apogee Therapeutics
- Apogee Therapeutics: Funding Supports Best-In-Class Ambitions In Atopic Dermatitis
- Apogee falls after results from atopic dermatitis trial
- Seeking Alpha’s Quant Rating on Apogee Therapeutics
- Historical earnings data for Apogee Therapeutics
- Financial information for Apogee Therapeutics
推荐文章
一图看懂 | 净利润大幅增长！阿里Q2净利同比增76%至424亿元；闪购业务引流效果显著
一周财经日历 | 大小非农数据来袭，能否决定9月降息计划？蔚来、博通财报压轴登场
一周IPO丨打新“赚钱效应”爆表！佳鑫国际首日飙涨177%；大行科工、劲方医药或即将启动招股
【A+H】禾赛科技回港上市获备案 面临募资与定价双重考验
特朗普试图解雇美联储理事库克，美股为何无动于衷？一文解读
自动驾驶成负面资产！调查显示：FSD降低消费者购买特斯拉意愿
还能领先多久？从4月美股触底算起：亚洲科技股持续跑赢纳斯达克100
美股机会日报 | 史上最快破万亿，美企正以创纪录速度回购！绩优股走强，Snowflake绩后大涨超14%
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
